Proof of Usefulness Report

STMPatch

Analysis completed on 2/3/2026

+21
Proof of Usefulness Score
You're In Business

The project proposes a high-utility biotechnology concept (microneedle vaccine patches), but the submission is severely undermined by verifiable falsehoods and poor data quality. The claim that 'most people have used my product' is factually incorrect for a regulated medical device in this stage. Additionally, the metadata (e.g., 'energy-solutions' tag) contradicts the biotech description, and the email format is irregular. While the core scientific concept is sound, there is zero credible evidence of traction, execution, or market readiness provided.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+39.0
Audience Reach Impact+2.5
Technical Innovation+48.0
Evidence Of Traction+0.0
Market Timing Relevance+56.0
Functional Completeness+5.0
Subtotal+23
Usefulness Multiplierx0.91
Final Score+21

Project Details

Project URL
Description
The SingleTimeMicroneedle Patch allows vaccines to be delivered via transdermal patch that painlessly embeds bodily degradable microneedles in the skin. The microneedles can be programmed for delivery over time and at specific times, requires no refrigeration, and can be self-administered by patients. The core technology of STM is a vaccine patch which can be painlessly applied at a single time on the skin to embed arrays of microneedles (MNs) inside the superficial skin layer (like an invisible tattoo). The MNs are made of a safe biodegradable polymer (used for surgical suture) and pre-programmed to release vaccines repeatedly over a long period, mimicking the effect of multiple prime/booster doses in the traditional vaccination process. The vaccines (including subunit protein-based antigen, vector-based vaccine or mRNAs) are stabilized against high temperatures, thus avoiding the need of cold-chain storage facilities and affirming the antigenicity for a long-term skin embedment. The technology will revolutionize the vaccination process by (1) enabling a high immunogenic efficacy via transdermal delivery, (2) enhancing patient compliance via the use of painless and self-administered skin patch, and (3) removing the logistic/economic burden to store vaccines at high temperatures. This skin patch could also be applied for animal vaccination, offering a high impact on both healthcare and other industry sectors.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline